RIGL Operating Cash Flow (Statement)

Rigel Pharmaceuticals Inc · Operating Cash Flow (Statement)

RIGL logo

RIGL Operating Cash Flow (Statement)

Latest reported$30.65M
RIGL Quarterly Cash from Operations (-$4.91M → $30.65M)
High-resolution chart · PNG

RIGL operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
30,653,000
2,725,000
21,980,000
24,031,000
30,537,000
-893,000
14,503,000
21,679,000
302,000
-5,013,000
-6,240,000
-1,359,000
5,930,000
-4,074,000
-21,909,000
-13,301,000
-12,911,000
-25,637,000
-19,086,000
-10,297,000
55,216,000
-19,955,000
-15,572,000
-19,482,000
-14,038,000
-3,093,000
-9,649,000
-14,641,000
-16,651,000
-569,000
11,644,000
-20,082,000
-26,994,000
-23,394,000
-19,715,000
-17,610,000
-19,470,000
-20,762,000
-12,464,000
-22,571,000
-18,434,000
-22,420,000
-13,797,000
-9,457,000
-18,146,000
17,987,000
-15,050,000
-18,331,000
-19,944,000
-16,428,000
-18,886,000
-20,743,000
-21,321,000
-25,111,000
-21,554,000
-19,625,000
-20,740,000
-23,273,000
-18,654,000
-12,793,000
-17,165,000
-20,763,000
10,268,000
-19,008,000
78,575,000
-23,092,000
-23,274,000
-25,386,000
-25,057,000
-29,062,000
-27,140,000
-24,528,000
-24,770,000
-27,080,000
-8,375,000
-13,578,000
-14,817,000
-15,437,000
-10,887,000
-8,168,000
-6,636,000
-10,145,000
-4,495,000
-13,769,000
-10,812,000
-6,094,000
-5,276,000
-11,421,000
-10,875,000
-10,580,000
-9,849,000
-9,668,000
-8,663,000
-4,260,000
-14,592,000
-4,297,000
-10,687,000
-4,952,000
-2,976,000
-2,692,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.